All About Bevacizumab - Krzysztof Krzemieniecki - Books - LAP LAMBERT Academic Publishing - 9783659494116 - November 27, 2013
In case cover and title do not match, the title is correct

Krzysztof Krzemieniecki
All About Bevacizumab

Price
NZ$ 67
excl. VAT

Ordered from remote warehouse

Expected delivery Sep 30 - Oct 12
Get notified about new Krzysztof Krzemieniecki releases

Our customers say:

14-day return policy in accordance with European consumer protection law
Top ranking on Trustpilot
Add to your iMusic wish list

Not rated yet

Remission during sunitinib (a multikinase inhibitor and antiangiogenic drug) treatment correlates with appearance of macrocytosis. There are some suggestions that bevacizumab, an antiangiogenic drug, may result in macrocytosis as well. No available published data on the influence of bevacizumab on macrocytosis has been so far. This paper attempts to answer the question: does bevacizumab induce macrocytosis being a predictor of the response? Moreover, treatment of solid tumors and non-cancerous diseases is discussed in the second part of this paper.

Media Books     Paperback Book   (Book with soft cover and glued back)
Released November 27, 2013
ISBN13 9783659494116
Publishers LAP LAMBERT Academic Publishing
Pages 72
Dimensions 150 × 4 × 226 mm   ·   125 g
Language German  

See all of Krzysztof Krzemieniecki